Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Boehringer Ingelheim

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077167

« Back to Dashboard

NDA 077167 describes DIDANOSINE, which is a drug marketed by Aurobindo Pharma, Barr, Mylan Pharms Inc, and Aurobindo, and is included in five NDAs. It is available from four suppliers. Additional details are available on the DIDANOSINE profile page.

The generic ingredient in DIDANOSINE is didanosine. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the didanosine profile page.
Summary for 077167
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 077167
Medical Subject Heading (MeSH) Categories for 077167
Suppliers and Packaging for NDA: 077167
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167 ANDA Teva Pharmaceuticals USA, Inc. 0555-0588 N 0555-0588-01
DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167 ANDA Teva Pharmaceuticals USA, Inc. 0555-0589 N 0555-0589-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength200MG
Approval Date:Dec 3, 2004TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength250MG
Approval Date:Dec 3, 2004TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength400MG
Approval Date:Dec 3, 2004TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.